Relative study of cancer targeting potential of engineered dendrimer

CHF 69.55
Auf Lager
SKU
C70KV7CKJLD
Stock 1 Verfügbar
Geliefert zwischen Mo., 23.02.2026 und Di., 24.02.2026

Details

The present book discussed development and comparison of the tumor-targeting propensity of ligand decorated dendrimers. Folate-, dextran-, and galactose-anchored PPI dendrimers were synthesized by divergent method, characterized and evaluated for cell cytotoxicity assay. The outcome of project depicted the order of targeting affinity of different ligands under investigation as folate dextran galactose. The conclusion is estimated to be of higher scientific value and is assumed to help researcher in choice of targeting ligands.

Autorentext

Dr. Prashant Kesharwani grew up in Sagar, India. In 2014, he obtained his PhD degree from Dr H. S. Gour University, Sagar. Dr. Kesharwani currently works as aPost-Doc Fellow in Wayne State University,USA. An overarching goal of his current research is development of nano drug deliver systems. He co-authored more than 25 international publications.

Weitere Informationen

  • Allgemeine Informationen
    • Sprache Englisch
    • Autor Prashant Kesharwani
    • Titel Relative study of cancer targeting potential of engineered dendrimer
    • Veröffentlichung 19.03.2015
    • ISBN 3659517410
    • Format Kartonierter Einband (Kt)
    • EAN 9783659517419
    • Jahr 2015
    • Größe H220mm x B150mm x T9mm
    • Gewicht 227g
    • Genre Medizin
    • Anzahl Seiten 140
    • Herausgeber LAP LAMBERT Academic Publishing
    • GTIN 09783659517419

Bewertungen

Schreiben Sie eine Bewertung
Nur registrierte Benutzer können Bewertungen schreiben. Bitte loggen Sie sich ein oder erstellen Sie ein Konto.
Made with ♥ in Switzerland | ©2025 Avento by Gametime AG
Gametime AG | Hohlstrasse 216 | 8004 Zürich | Schweiz | UID: CHE-112.967.470
Kundenservice: customerservice@avento.shop | Tel: +41 44 248 38 38